ACTIVE

MA-EL RX

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

110,2 k €

+48.6% YoY

Gross margin

187,2 k €

+30.2% YoY

Equity

505,5 k €

+19.6% YoY

Workforce

0,2 ETP

0.0% YoY

What does MA-EL RX do?

MA-EL RX is a Private limited company incorporated in 2003. Its main activity is: Specialist medical practice activities. Its registered office is in Braine-l'Alleud. It employs on average 0,2 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0859.704.565

Incorporation

16/06/2003

Legal form

Private limited company

Registered office

Av la Douce Colline 22
1420 Braine-l'Alleud · WallonieSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Average workforce

0,2 ETP

Activities (NACE)

86220Specialist medical practice activities· main 86220Specialist medical practice activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	187,2 k €	+30.2%	143,7 k €	-50.9%	292,4 k €	+149%	117,3 k €	-5.9%	124,6 k €	-19.6%	155 k €	-13.3%	178,7 k €	+3.5%	172,6 k €	+4.3%	165,4 k €	+2.5%	161,4 k €	-32.3%	238,3 k €	+47.7%	161,3 k €	+57.1%	102,7 k €	-41.7%	176,2 k €	-18.9%	217,3 k €	-6.1%	231,5 k €	-7.8%	251 k €	+22.7%	204,5 k €	+6.5%	192,1 k €	+75.9%	109,2 k €
EBITDA	174 k €	+32.8%	131 k €	-53.2%	280,2 k €	+166%	105,5 k €	-11.0%	118,6 k €	-20.9%	149,8 k €	-13.5%	173,1 k €	+3.7%	166,9 k €	+3.0%	162,1 k €	+12.5%	144 k €	-26.4%	195,6 k €	+41.3%	138,4 k €	+36.0%	101,8 k €	-41.8%	174,9 k €	-17.2%	211,2 k €	-8.4%	230,5 k €	-7.2%	248,3 k €	+22.4%	202,8 k €	+5.9%	191,5 k €	+76.3%	108,6 k €
Operating result	168,3 k €	+49.9%	112,2 k €	-55.9%	254,7 k €	+230%	77,2 k €	-16.9%	92,9 k €	-26.0%	125,7 k €	-15.5%	148,7 k €	+4.1%	142,7 k €	-0.3%	143,2 k €	+19.2%	120,1 k €	-26.8%	164,1 k €	+60.0%	102,6 k €	+97.1%	52 k €	-54.8%	115,3 k €	-19.8%	143,7 k €	-16.9%	172,9 k €	-8.0%	187,9 k €	+24.9%	150,4 k €	+5.6%	142,4 k €	+178%	51,3 k €
Net result	110,2 k €	+48.6%	74,2 k €	-56.3%	169,8 k €	+243%	49,4 k €	-19.5%	61,4 k €	-29.8%	87,5 k €	-22.9%	113,4 k €	+7.8%	105,2 k €	+4.5%	100,7 k €	-6.3%	107,5 k €	+5.3%	102 k €	+69.3%	60,3 k €	+127%	26,5 k €	-60.4%	66,9 k €	-23.7%	87,7 k €	-16.9%	105,5 k €	-5.1%	111,2 k €	+6.2%	104,8 k €	-9.3%	115,5 k €	+244%	33,6 k €
Balance sheet
Equity	505,5 k €	+19.6%	422,8 k €	+12.2%	376,8 k €	+81.3%	207,8 k €	+30.6%	159,1 k €	+62.9%	97,7 k €	+24.0%	78,8 k €	+53.5%	51,3 k €	+122%	23,1 k €	+3.1%	22,4 k €	+50.0%	14,9 k €	+0.3%	14,9 k €	+1.7%	14,6 k €	-9.3%	16,1 k €	+13.0%	14,3 k €	-14.0%	16,6 k €	-21.2%	21,1 k €	+6.2%	19,9 k €	-34.0%	30,1 k €	+106%	14,6 k €
Total assets	575,6 k €	+27.3%	452,1 k €	-12.0%	514,1 k €	+58.3%	324,7 k €	-2.6%	333,3 k €	-0.9%	336,4 k €	-0.0%	336,5 k €	-10.3%	375,3 k €	+34.7%	278,6 k €	-23.5%	364,4 k €	-6.0%	387,5 k €	+9.3%	354,5 k €	+97.4%	179,5 k €	-32.2%	264,7 k €	-24.2%	349,2 k €	+22.9%	284,2 k €	-9.7%	314,9 k €	-22.7%	407,5 k €	+14.0%	357,4 k €	-2.7%	367,4 k €
Cash	121,8 k €	-32.7%	181 k €	-12.5%	206,8 k €	+2014%	9,8 k €	-33.5%	14,7 k €	-48.2%	28,4 k €	+159%	10,9 k €	+384%	2,3 k €	-83.1%	13,4 k €	+2821%	458,9 €	-4.9%	482,5 €	-82.3%	2,7 k €	+489%	461,7 €	-97.7%	20,3 k €	+74.8%	11,6 k €	-28.2%	16,2 k €	-7.9%	17,6 k €	-36.5%	27,7 k €	+213%	8,9 k €	-88.6%	77,5 k €
Debts	65,1 k €	+168%	24,3 k €	-57.0%	56,6 k €	-46.9%	106,5 k €	-33.9%	161,2 k €	-31.2%	234,5 k €	-6.9%	251,9 k €	-20.7%	317,8 k €	+26.4%	251,5 k €	-24.1%	331,5 k €	-9.2%	365 k €	+11.4%	327,6 k €	+124%	146,5 k €	-39.3%	241,4 k €	-23.8%	316,8 k €	+20.7%	262,4 k €	-8.7%	287,4 k €	-24.8%	382,1 k €	+16.7%	327,3 k €	-7.2%	352,8 k €
Other
Workforce	0,2 ETP	0.0%	0,2 ETP	0.0%	0,2 ETP		–		–		–		–		–		–		–		1,2 ETP	0.0%	1,2 ETP		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Marie LORENT

Director · since 01 octobre 2025

Active

Béatrice BOUCHE

Director · since 16 juillet 2003

Active

Ended mandates

Béatrice BOUCHE

Director · since 01 juillet 2003

Ended

Béatrice BOUCHE

Manager · since 01 juillet 2003

Ended

Béatrice BOUCHE

Director · since 16 juin 2003

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	13/07/2026	08/07/2025	26/07/2024	27/07/2023	21/06/2022	17/06/2021
General meeting	09/06/2026	10/06/2025	30/06/2024	30/06/2023	14/06/2022	08/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	09/06/2026	13/07/2026	French	PDF
Abridged model	31/12/2024	10/06/2025	08/07/2025	French	PDF
Abridged model	31/12/2023	30/06/2024	26/07/2024	French	PDF
Micro model	31/12/2022	30/06/2023	27/07/2023	French	PDF
Micro model	31/12/2021	14/06/2022	21/06/2022	French	PDF
Micro model	31/12/2020	08/06/2021	17/06/2021	French	PDF
Micro model	31/12/2019	09/06/2020	12/06/2020	French	PDF
Micro model	31/12/2018	11/06/2019	21/06/2019	French	PDF
Micro model	31/12/2017	12/06/2018	28/06/2018	French	PDF
Micro model	31/12/2016	13/06/2017	30/06/2017	French	PDF
Abridged model	31/12/2015	14/06/2016	04/07/2016	French	PDF
Abridged model	31/12/2014	30/06/2015	27/07/2015	French	PDF
Abridged model	31/12/2013	10/06/2014	12/06/2014	French	PDF
Abridged model	31/12/2012	28/06/2013	24/07/2013	French	PDF
Abridged model	31/12/2011	12/06/2012	27/06/2012	French	PDF
Abridged model	31/12/2010	14/06/2011	15/06/2011	French	PDF
Abridged model	31/12/2009	08/06/2010	24/06/2010	French	PDF
Abridged model	31/12/2008	09/06/2009	11/06/2009	French	PDF
Abridged model	31/12/2007	10/06/2008	12/06/2008	French	PDF
Abridged model	31/12/2006	03/07/2007	25/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Marie LORENT

Director · since 01 octobre 2025

Active

Béatrice BOUCHE

Director · since 16 juillet 2003

Active

Ended mandates

Béatrice BOUCHE

Director · since 01 juillet 2003

Ended

Béatrice BOUCHE

Manager · since 01 juillet 2003

Ended

Béatrice BOUCHE

Director · since 16 juin 2003

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates13/10/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates19/12/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DIVERS - DEMISSIONS, NOMINATIONS
PDF
Other22/12/2003
DIVERS
PDF
Other28/07/2003
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025110,2 k €↑
2024
Annual accounts 202474,2 k €↓
2023
Annual accounts 2023169,8 k €↑
2022
Annual accounts 202249,4 k €↓
2021
Annual accounts 202161,4 k €↓
2020
Annual accounts 202087,5 k €↓
2019
Annual accounts 2019113,4 k €↑
2018
Annual accounts 2018105,2 k €↑
2017
Annual accounts 2017100,7 k €↓
2016
Annual accounts 2016107,5 k €↑
2015
Annual accounts 2015102 k €↑
2014
Annual accounts 201460,3 k €↑
2013
Annual accounts 201326,5 k €↓
2012
Annual accounts 201266,9 k €↓
2011
Annual accounts 201187,7 k €↓
2010
Annual accounts 2010105,5 k €↓
2009
Annual accounts 2009111,2 k €↑
2008
Annual accounts 2008104,8 k €↓
2007
Annual accounts 2007115,5 k €↑
2006
Annual accounts 200633,6 k €
16/06/2003
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

MA-EL RX

Overview

What does MA-EL RX do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline